Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation
…
3,980€
-5,24%
Echtzeit-Aktienkurs Achieve Life Sciences
Bid:
Ask:
Nachrichten zur Achieve Life Sciences Aktie
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities
SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a…
Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering
SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a…
Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk
…
Rubedo Life Sciences gibt bekannt, dass der erste Patient mit dem führenden Medikamentenkandidaten RLS-1496 behandelt wurde, dem ersten GPX4-Modulator, der auf pathologische seneszente Zellen abzielt und in die klinische Phase 1 eintritt
SAN FRANCISCO--(BUSINESS WIRE)--Rubedo Life Sciences, Inc. (Rubedo), ein KI-gesteuertes Biotech-Unternehmen im klinischen Stadium, das sich auf die Erforschung und schnelle…
Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript
…
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine
ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo…
Achieve Life Sciences announces board changes By Investing.com
Achieve Life Sciences announces board changes…
Achieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call Transcript
…
Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement
…
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a…
Achieve Life Sciences, Inc. (ACHV) Q1 2024 Earnings Call Transcript
…
Jones Trading sets stock target on Achieve Life Sciences shares By Investing.com
Jones Trading sets stock target on Achieve Life Sciences shares…
Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns
…
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript
…
Achieve Life Sciences Q4 2023 Earnings Preview
…
Achieve Life Sciences secures $60 million in funding By Investing.com
Achieve Life Sciences secures $60 million in funding…